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Introduction 
•  Lyme disease is the most common tick-borne infection  
in the US and Europe.
•  Clinical manifestations
   Early localized 
    Single erythema migrans 3-30 days following tick bite
   Early disseminated 
    Multiple erythema migrans, cranial nerve palsy, 
meningitis, carditis after 1-4 weeks
   Late disseminated 
    Weeks to months after initial infection 
    Arthritis is the most common manifestation of late 
Lyme disease in children
•  Diagnosed by clinical presentation followed by 
confirmation of infection by serologic testing
•  Treatment is based on age and clinical presentation
   Regardless of age, treatment of choice for early 
localized disease or early disseminated disease without 
cerebrospinal fluid (CSF) findings is doxycycline per the 
2018 edition of the RED Book
   Intravenous Ceftriaxone is reserved for meningitis, 
encephalitis or severe carditis
   Arthritis without neurologic disease can be treated  
with doxycycline or amoxicillin
•  Upon review of literature, there has not been a detailed 
collection of cases of Lyme disease in pediatric patients 
in Eastern Pennsylvania, a Lyme endemic area.
•  This retrospective study aims to produce an updated 
review of Lyme Disease seen in a community hospital 
setting in children in Eastern Pennsylvania, and to 
characterize the clinical presentations, treatments, and 
persistence or duration of the disease in childhood.
Methods
Retrospective chart review of data from patients 
18 years old or younger who received care at 
Lehigh Valley Health Network (LVHN), including 
the Inpatient, Outpatient and Emergency 
Department settings, with a diagnosis of Lyme 
disease. The review consisted of data on patients 
who were diagnosed with Lyme from January 
2014 to September 2018, encompassing charts 
from when our institution implemented EpicTM. 
Lyme disease was defined as clinical symptoms 
in children with laboratory confirmation by C6 
antibody, Western Blot, or other standardized 
tests, or a child identified as having early 
localized disease with erythema migrans. 
Results
Table 1: Demographic Distribution







Black/African American 4 1.3
Other 25 8.0
Age
< 6 176 56.1
≥ 6 < 14 115 36.6
≥ 14 < 19 23 7.3
Discussion
•  Clinical Presentations (Figure 1, Table 2)
   Almost 2/3 of cases were early localized disease 
    Only 179 had documented erythema migrans
   •  Parents solely reporting rash v. poor 
documentation
   Early disseminated disease 
    Multiple Erythema migrans most common 
presentation
   Late disseminated disease least common
•  Testing (Figure 2)
   ELISA with confirmatory Western Blot most 
common
   PCR mainly done on synovial fluid, not appropriate 
test for blood
•  Treatment (Figure 3)
   Amoxicillin most common treatment, followed  
by Doxycycline
Conclusion
Thus far this study focused on characterizing the 
clinical presentations, treatments, and outcomes of 
Lyme disease in children in the Lehigh Valley. Further 
research will be performed to not only compile 
additional retrospective data, but also to achieve a 
secondary objective of determining if there is a 
significant relationship between clinical presentation  
of Lyme disease and the results of diagnostic testing, 
age, time to resolution/cure, or reported tick bite. 





 IgM Positive 33
 IgG Positive 38
 IgM & IgG Positive 53
 *per patient
 Synovial Fluid 4
 CSF 0


















Negative 8 2 1
 IgM Positive 21 12 0
 IgG Positive 14 5 19
 IgM & IgG Positive 6 15 32
Figure 3: First Course Antibiotic Choice 
 













Of the 84 cases of children <8yo in 2018 and 
2019, 71 were treated with Amoxicillin and 8 were 
treated with Doxycycline. Of the 135 cases of 
children <8yo prior to 2018, 119 were treated with 
Amoxicillin and 5 were treated with Doxycycline. 
For all years, of the 219 cases of children <8yo, 
190 were treated with Amoxicillin and 13 were 
treated with Doxycycline.










Table 2: Clinical Presentation 
Clinical Presentation Number of Patients (%)
Early Localized 202
Single Erythema Migrans 179 88.6
Early Disseminated 58  
Meningitis 1 1.7
Facial Nerve Palsy 14 24.1
Carditis 0 0
Multiple Erythema Migrans 43 74.1
Other Nervous System 8 13.8
Late Disseminated 54  
Arthritis 54 100.0
